Display options
Cite
McVerry BA, Ross MG, Knowles WA, et al. Viral exposure and abnormal liver function in haemophilia. J Clin Pathol. 1979;32(4):377-81doi: 10.1136/jcp.32.4.377.
McVerry, B. A., Ross, M. G., Knowles, W. A., & Voke, J. (1979). Viral exposure and abnormal liver function in haemophilia. Journal of clinical pathology, 32(4), 377-81. https://doi.org/10.1136/jcp.32.4.377
McVerry, B A, et al. "Viral exposure and abnormal liver function in haemophilia." Journal of clinical pathology vol. 32,4 (1979): 377-81. doi: https://doi.org/10.1136/jcp.32.4.377
McVerry BA, Ross MG, Knowles WA, Voke J. Viral exposure and abnormal liver function in haemophilia. J Clin Pathol. 1979 Apr;32(4):377-81. doi: 10.1136/jcp.32.4.377. PMID: 221550; PMCID: PMC1145676.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

J Clin Pathol. 1979 Apr;32(4):377-81. doi: 10.1136/jcp.32.4.377.

Viral exposure and abnormal liver function in haemophilia.

Journal of clinical pathology

B A McVerry, M G Ross, W A Knowles, J Voke

PMID: 221550 PMCID: PMC1145676 DOI: 10.1136/jcp.32.4.377
Free PMC Article

Abstract

Several studies have recently documented the presence of persistently abnormal liver function tests in asymptomatic haemophiliacs. While the aetiology is unknown it is possible that repeated exposure to agents transmitted in blood products may be important. This study has attempted to determine the prevalence of viral exposure and its relationship to liver function in this multitransfused group of individuals. The prevalence of viral antibodies with the exception of antibody to hepatitis B surface antigen (anti-HBs) and cytomegalovirus (CMV) was normal when compared to that in the general population. Hepatitis B surface antigen (HBsAg) was not detected, but anti-HBs was found in 83% of patients; 50% of patients had abnormal liver function. However, liver function tests were normal in all patients with mild haemophilia and were only rarely abnormal in patients who had no detectable antibody to CMV, Epstein-Barr virus (EBV), and HBsAg. This study demonstrates that multiple transfusions of blood products, that is, cryoprecipitate and factor concentrates, do not increase the risk of exposure to the viruses studied with the exception of hepatitis B virus.

Similar articles

Cited by

References

  1. Mon Bull Minist Health Public Health Lab Serv. 1962 May;21:96-104 - PubMed
  2. Scand J Haematol Suppl. 1977;30:16-26 - PubMed
  3. Scand J Haematol Suppl. 1977;30:11-5 - PubMed
  4. J Clin Pathol. 1977 Dec;30(12):1142-6 - PubMed
  5. J Clin Pathol. 1978 Apr;31(4):309-12 - PubMed
  6. Blood. 1977 Jul;50(1):1-9 - PubMed
  7. Ann Intern Med. 1977 Jun;86(6):703-7 - PubMed
  8. Transfusion. 1977 Sep-Oct;17(5):495-9 - PubMed
  9. Transfusion. 1977 Sep-Oct;17(5):490-4 - PubMed
  10. N Engl J Med. 1978 Jun 22;298(25):1373-8 - PubMed
  11. J Hyg (Lond). 1978 Jun;80(3):327-36 - PubMed
  12. Br J Exp Pathol. 1977 Aug;58(4):352-8 - PubMed
  13. Lancet. 1978 Mar 4;1(8062):463-6 - PubMed
  14. Lancet. 1978 Mar 4;1(8062):459-63 - PubMed
  15. Gastroenterology. 1977 May;72(5 Pt 1):902-9 - PubMed
  16. Lancet. 1977 Mar 12;1(8011):560-2 - PubMed
  17. Br J Haematol. 1974 Mar;26(3):313-29 - PubMed
  18. Vox Sang. 1973 Jan;24(1):66-75 - PubMed
  19. Lancet. 1972 Mar 25;1(7752):665-7 - PubMed
  20. Lancet. 1974 Feb 9;1(7850):194-7 - PubMed
  21. Br Med Bull. 1972 May;28(2):180-5 - PubMed
  22. J Clin Pathol. 1975 Aug;28(8):620-4 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources